I'm LongbridgeAI, I can summarize articles.Each week, Benzinga’s Stock Whisper Index uses proprietary data and pattern recognition to highlight five stocks just under the surface that deserve attention.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. Retail traders have countless methods at their disposal. Sifting through available information to uncover new opportunities and understand why certain stocks matter can be challenging.
Here’s a look at the Benzinga Stock Whisper Index for the week ending Nov. 20:
Analog Devices (NASDAQ:ADI): The chipmaker saw strong interest from readers during the week. The company reports fourth-quarter financial results on Tuesday with analysts expecting earnings per share of $3.88 and revenue of $4.31 billion. Those figures compare to $2.26 and $3.08 billion last year, respectively. The company has beaten both earnings and revenue estimates in more than 10 straight quarters. Analog Devices saw an initiation from Roth Capital ahead of earnings with a Buy rating and price target of $505. The stock is one to watch after a double-digit pullback on the week.

Lam Research Corporation (NASDAQ:LRCX): The semiconductor-related company saw strong interest and continues to be one of the most followed stocks by Benzinga readers. Shares were down 14% on the week and are now in negative territory year-to-date, which comes after trading at $438.50 in June of this year. A recent positive for the company is David Tepper’s Appaloosa Management revealing a 63% increased position in a third quarter filing. The company also partnered with LEGO on a STEM learning program. Lam presents at an upcoming UBS conference on Dec. 1, which could serve as a catalyst.

Revolution Medicines (NASDAQ:RVMD): The Stock Whisper Index doesn’t typically include clinical stage biotech companies, but this week’s interest and news from Revolution Medicines warrants an inclusion. The company reported Phase 1/2 updated results for an open-label study of Rasonque in combination with gemcitabine and nab-paclitaxel as a potential first-line treatment for metastatic pancreatic adenocarcinoma. The impressive results helped put the spotlight on the stock, which is up over 100% year-to-date. Along with the update the company also began treating patients for a global Phase 3 clinical study for its metastatic lung cancer treatment in October. While shares are up over 100% in 2026, the biotech stock is one to watch.

Simon Property Group (NYSE:SPG): The largest retail REIT saw strong interest from readers during the week. This comes after the company reported third-quarter financial results earlier this month. While the results were mixed, the company raised its full-year FFO outlook and raised its dividend. Analysts were impressed with results and guidance with the stock receiving multiple price target increases.

Johnson & Johnson (NYSE:JNJ): The well-known healthcare company makes the list for the week with shares down around 6%. Shares are up 30% year-to-date and trade near all-time highs. The large cap medicine and medtech company recently released several news items that investors shouldn’t miss. The company is acquiring clinical stage biotech Ollin Biosciences. Ollin is focused on eye diseases and the portfolio could boost the company’s presence in that field. The company also announced recent Phase 3 results for its bipolar I disease treatment CAPLYTA. The results showed primary and secondary endpoints met. Given the company’s size and market capitalization it takes a large catalyst or multiple catalysts to move the share price. These announcements were positives and several other drug updates have been shared this month. For a large cap stock receiving increased attention from readers, the company is one to watch heading into 2027.

Stay tuned for next week’s report, and follow Benzinga Pro for all the latest headlines and top market-moving stories here.
Read the latest Stock Whisper Index reports here:
- October 16
- October 23
- October 30
- November 7
- November 13
Read Also: EXCLUSIVE: Top 12 Most-Searched Tickers in October on Benzinga Pro – SpaceX Soars, Micron Rises, Nvidia Falls, CoreWeave and Microsoft Join List
Login to unlock3,029characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.
